Latest Australian Markets News

Clarity Pharmaceuticals bolsters its commercial readiness with a $178.3 million cash reserve and a key US manufacturing agreement, while clinical trials for its prostate cancer imaging and therapeutic agents progress with promising data.

Comet Ridge has completed a $40.9 million capital raise combining a Share Purchase Plan and a two-tranche placement to fund full acquisition and development of its Mahalo Gas Project.

OncoSil Medical reported a 53% increase in unit sales and advanced key regulatory approvals, including FDA final review and TGA listing, positioning it for growth in pancreatic cancer treatment.

Audeara Ltd posted record FY26 cash receipts of $4.2 million and unaudited revenue of $4.44 million, driven by progress in AI audio licensing, exclusive assistive listening deals, and a large-scale Auracast deployment across retirement villages.

X2M Connect has secured $2 million in a placement to boost its data centre and AI energy management platform, with a fully underwritten $1 million Securities Purchase Plan to follow. The capital raise supports sensor integration, platform enhancements, and battery energy systems aimed at cutting data centre precinct energy costs by up to 20%.

Yowie Group’s latest quarters reveal falling revenues and shrinking cash reserves, even as new leadership and product launches aim to stabilise the confectionery maker’s turnaround.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for its suite of 27 ETFs on the ASX, updating investment strategies, fee structures, risk factors, and operational details.

TradeWindow Holdings reported a 20% increase in trading revenue to $9.6 million and improved its EBITDA loss to $1.2 million, while advancing its AI-driven FreightAI platform on track for a 2027 commercial release.

Janus Electric has secured a A$10 million order from US fleet Ability Tri-Modal, lifting its North American diesel-to-electric truck conversions to 45 and advancing commercial rollouts in Canada and Australia.

Future Generation Australia (ASX: FGX) reported a robust 20.1% total shareholder return for the year to June 2026 alongside an increased fully franked interim dividend of 3.8 cents per share, maintaining its commitment to steady income and social impact.

CDC’s independent valuation jumped 23.6% to a mid-point of A$18.5 billion, propelled by contracted capacity exceeding 1GW and a major pipeline expansion to 3.9GW. Infratil’s nearly 50% stake now values at over A$9.2 billion.

Global X Management (AUS) Limited is trimming the management fee for its Australia 300 ETF (ASX: A300) by 25%, effective 1 July 2026, reflecting a subtle but meaningful cost saving for investors.